Small Cell Lung Cancer: Limited Disease
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-642-18698-1_24
Reference45 articles.
1. Arquette M, Wasserman T, Govindan R et al. (2002) Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation, Semin Radiat Oncol 12 (suppl 1):59–61
2. Arriagada R, Kramer A, Le Chevalier T et al. (1992) Competing events determining the relapse-free survival in limited stage small-cell lung carcinoma. J Clin Oncol 10:447–451
3. Arriagada R, Le Chevalier T, Pignon JP (1993) Initial chemotherapeutic doses and survival in patients with limited stage small cell lung cancer. N Engl J Med 329: 1848–1852
4. Bonner J, Sloan J, Shanahan T et al. (1999) Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited small-cell lung carcinoma. J Clin Oncol 17: 2681–2691
5. Bremnes R, Sundstrom S, Vilsvik J, Aasebo U for the Norwegian Lung Cancer Study Group (2001) Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer. J Clin Oncol 19: 3532–3538
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3